The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: A population-based cohort study.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
05 2022
Historique:
received: 05 01 2022
revised: 16 03 2022
accepted: 17 03 2022
pubmed: 2 4 2022
medline: 4 5 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

This study aimed to investigate how different timelines of various dental therapies were related to osteoradionecrosis development under consideration of radiotherapy dosage in patients with oral cancer. A total of 7,107 oral cancer patients were enrolled, including 88 osteoradionecrosis patients treated with low radiotherapy dosages (<60 Gy) or high radiotherapy dosages (≥60 Gy), from the Longitudinal Health Insurance Database for Catastrophic Illness Patients of Taiwan. Cox proportional hazard regression was used to compare the osteoradionecrosis risk of various dental treatment timelines under different irradiation dosages. In the oral cancer population with low irradiation dosages (<60 Gy), performing periodontal therapy combined with irradiation significantly raised the risk of osteoradionecrosis by 2.21-fold. Starting radiotherapy within three months after dental surgery greatly increased the risk of developing osteoradionecrosis by 1.87-fold. The oral cancer patients treated with high radiation doses (≥60 Gy) receiving dental surgery within one month prior to radiotherapy had a significantly raised osteoradionecrosis occurrence by 1.60-fold. While the dental surgery was performed during the radiotherapy course, the risk of osteoradionecrosis was greatly increased by 2.21-fold. For oral cancer patients, performing dental surgery within three months before radiotherapy might significantly induce osteoradionecrosis. Patients that were treated with high irradiation dosages (≥60 Gy) had a higher tendency to develop osteoradionecrosis if they received dental surgery during radiotherapy. Those who were treated with low radiation dosages (<60 Gy) and received periodontal therapy during radiotherapy might have an increased risk in developing osteoradionecrosis.

Identifiants

pubmed: 35364549
pii: S1368-8375(22)00116-6
doi: 10.1016/j.oraloncology.2022.105827
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105827

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Chung-Ta Chang (CT)

Department of Emergency Medicine, Far Eastern Memorial Hospital, New Taipei 22056, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan 32003, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan.

Shih-Ping Liu (SP)

Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan; Center for Neuropsychiatry, China Medical University Hospital, Taichung 40402, Taiwan; Department of Social Work, Asia University, Taichung 41354, Taiwan.

Chih-Hsin Muo (CH)

Management Office for Health Data, China Medical University Hospital, Taichung 40402, Taiwan.

Yu-Fang Liao (YF)

Department of Craniofacial Orthodontics, Chang Gung Memorial Hospital, Taipei 10507, Taiwan; Craniofacial Center, Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan; Craniofacial Research Center, Chang Gung Memorial Hospital, Linkou 33305, Taiwan; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.

Kuan-Ming Chiu (KM)

Division of Cardiovascular Surgery, Cardiovascular Center, Far-Eastern Memorial Hospital, New Taipei 22056, Taiwan; Department of Nursing, Oriental Institute of Technology, New Taipei 22056, Taiwan; Department of Electrical Engineering, Yuan Ze University, Taoyuan 32003, Taiwan.

Chun-Hao Tsai (CH)

Graduate Institute of Clinical Medicine, China Medical University, Taichung 40402, Taiwan; Department of Orthopedics, China Medical University Hospital, Taichung 40402, Taiwan.

Yi-Fang Huang (YF)

School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan; Graduate Institute of Dental and Craniofacial Science, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan; Department of General Dentistry, Chang Gung Memorial Hospital, Linkou 33305, Taiwan. Electronic address: a7506@cgmh.org.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH